Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants.

× No keyword cloud information.

12 in total

Review 1. Personalized medicine: is it a pharmacogenetic mirage?

Authors: Rashmi R Shah; Devron R Shah
Journal: Br J Clin Pharmacol Date: 2012-10 Impact factor: 4.335

Review 2. The pharmacology of novel oral anticoagulants.

Authors: Tracy A DeWald; Richard C Becker
Journal: J Thromb Thrombolysis Date: 2014 Impact factor: 2.300

3. Warfarin pharmacogenomics.

Authors: Jiayi Li; Shan Wang; Joseph Barone; Brian Malone
Journal: P T Date: 2009-08

4. CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.

Authors: Matthew G McDonald; Mark J Rieder; Mariko Nakano; Clara K Hsia; Allan E Rettie
Journal: Mol Pharmacol Date: 2009-03-18 Impact factor: 4.436

5. High-resolution SNP and haplotype maps of the human gamma-glutamyl carboxylase gene (GGCX) and association study between polymorphisms in GGCX and the warfarin maintenance dose requirement of the Japanese population.

Authors: Pei-Chieng Cha; Taisei Mushiroda; Atsushi Takahashi; Shigeru Saito; Hideki Shimomura; Takao Suzuki; Naoyuki Kamatani; Yusuke Nakamura
Journal: J Hum Genet Date: 2007-09-05 Impact factor: 3.172

6. Prevalence of combinatorial CYP2C9 and VKORC1 genotypes in Puerto Ricans: implications for warfarin management in Hispanics.

Authors: Jorge Duconge; Carmen L Cadilla; Andreas Windemuth; Mohan Kocherla; Krystyna Gorowski; Richard L Seip; Kali Bogaard; Jessica Y Renta; Paola Piovanetti; Darrin D'Agostino; Pedro J Santiago-Borrero; Gualberto Ruaño
Journal: Ethn Dis Date: 2009 Impact factor: 1.847

7. Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients.

Authors: Masako Ohno; Akiko Yamamoto; Ayumu Ono; Genta Miura; Masanobu Funamoto; Yasuhiko Takemoto; Kinya Otsu; Yasushi Kouno; Tomoko Tanabe; Yuiko Masunaga; Shinpei Nonen; Yasushi Fujio; Junichi Azuma
Journal: Eur J Clin Pharmacol Date: 2009-07-07 Impact factor: 2.953

Review 8. Pharmacogenetics of healthy volunteers in Puerto Rico.

Authors: Karla Claudio-Campos; Carmelo Orengo-Mercado; Jessicca Y Renta; Muriel Peguero; Ricardo García; Gabriel Hernández; Susan Corey; Carmen L Cadilla; Jorge Duconge
Journal: Drug Metab Pers Ther Date: 2015-12

Review 9. Warfarin pharmacogenetics.

Authors: Nita A Limdi; David L Veenstra
Journal: Pharmacotherapy Date: 2008-09 Impact factor: 4.705

10. Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study.

Authors: Sam Schulman; Rajae Elbazi; Michelle Zondag; Martin O'Donnell
Journal: Thromb J Date: 2008-10-16